Radial approach and single wiring as first intentional strategies in chronic total occlusions of the left anterior descending coronary artery

Size: px
Start display at page:

Download "Radial approach and single wiring as first intentional strategies in chronic total occlusions of the left anterior descending coronary artery"

Transcription

1 Radial approach and single wiring as first intentional strategies in chronic total occlusions of the left anterior descending coronary artery Yasser Nassar a,, Nicolas Boudou b, Didier Carrie b a Cairo University, Critical Care Dept; b Toulouse Rangueil University, Cardiology Dept a b Egypt; France Background: Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) of the left anterior descending coronary artery (LAD) specifically is associated with improved long-term 5 years survival as compared to PCI failure. Simpler PCI techniques may be successful and safer than complex techniques which are perceived to have high failure rates and technical complexity. We aimed to describe the safety and effectiveness of first intentional single wiring and radial approach in the treatment of patients with a CTO of the native LAD coronary artery at Toulouse Rangueil university hospitals. Patients and methods: The study was a single center prospective registry. All patients showed evidence of myocardial viability in LAD territory. The operators initial strategy was to start by a radial access as a first choice whenever feasible; if not, a femoral access was chosen. The initial strategy for lesion crossing in either antegrade or retrograde approaches was single wiring by lesion crossing using one guidewire (GW) as a simple technique. Results: A total of 30 patients with 30 LAD CTO lesions (100%) were recorded. Mean age was years, 77% were males and 23% were females. The access route was radial 66% of the time and femoral 54% of the time and with double access for contralateral injection in 40% of the patients. Sheaths and catheters sizes 6F were used in 53% of the patients, and 7F in 73% of the patients. Overall lesion success rate was 83% of lesions. Single wiring was the prevailing technique used in 97% of successful lesions (83% of total cases), while only 3% were by multiple wiring techniques. Successful single antegrade wiring represented 63% of our total study cases with a GW success rate of 92% of cases. Successful single retrograde wiring represented 13% of our cases with a GW success rate of 67%. Q-wave myocardial infarction (MI), stent thrombosis, stroke, emergency coronary artery bypass graft (CABG), major bleeding, radiation dermatitis, cardiac tamponade or clinical perforation requiring any hemostatic maneuvers did not occur. There was a post-procedural Troponin rise of 3x normal levels in 30% of patients, and contrast induced nephropathy in 7%. Intra-aortic balloon counterpulsation (IABCP) was used in 3% of patients and cardiac death occurred in 3% of patients. Conclusion: Single wiring and radial access as initial strategies in PCI for LAD-CTO lesions in either approaches antegrade or retrograde are associated with a high procedural success rate and an acceptable incidences of adverse events. Ó 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved. Keywords: Chronic, Total, Occlusion, Left anterior descending Received 30 November 2012; revised 11 February 2013; accepted 24 February Available online 16 March 2013 Corresponding author. Address: 2 gameat aldoal alarabiah st., flat 23, Giza 12311, Egypt. Tel.: addresses: ysnassar@hotmail.com, ysnassar@kasrelainy.edu.eg (Y. Nassar). P.O. Box 2925 Riyadh 11461KSA Tel: ext Fax: sha@sha.org.sa URL: Ó 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved. Peer review under responsibility of King Saud University. URL: Production and hosting by Elsevier

2 68 NASSAR ET AL Introduction Acoronary chronic total occlusion (CTO) is defined to be: the presence of a thrombolysis in myocardial infarction (TIMI) 0 flow within the occluded segment with an estimated occlusion duration of >3 months duration. [1,2] It is a common angiographic finding in 30% of patients undergoing coronary angiography, and in 52% of patients with significant coronary artery disease [3] demonstrating a very variable clinical presentation ranging from silent ischaemia, stable angina, ischemic heart failure, or discovered as a coincidence during a primary intervention for another culprit vessel [2]. Antegrade contrast filling of the segment beyond the occlusion can occur through intraluminal channels below the threshold of angiographic resolution [4], or non-intra-luminal ipsilateral bridging collaterals giving a false impression of a functional incomplete occlusion [4]. Retrograde contrast filling beyond the occlusion can occur through contralateral coronaries. The presence of collateral filling distal to the CTO is not a justification for a conservative approach since it only supplies 40% of the pressure level of the open artery [5] which is a barely sufficient blood flow to maintain viability of the myocardium supplied by the occluded artery [2]. It is almost always insufficient to avoid the effort induced angina/ischaemia, as during exercise, only about 5% of patients will have collaterals with enough functional reserve to increase collateral perfusion, whereas more than one-third of patients will experience coronary steal [6,7]. Almost half of the patients with CTOs do not have Q-waves or akinesia in the territory of the occluded artery [8,9] emphasizing the expected benefit of revascularization of ischaemic viable/hibernating myocardium in the CTO territory, even if the patient s symptoms are acceptably controlled or becomes asymptomatic by medical treatment. An untreated CTO is a strong predictor of 30 day and 5 year mortality after primary percutaneous coronary intervention (PCI) [10] and causing a threefold increase in cardiac mortality or complications in case of future acute events [11]. PCI recanalization of CTOs is more effective in reducing residual ischemia (>5%) [12]. And may provide better prognosis than optimal medical therapy alone. Its benefit is greatest in patients with moderate (10 20%) or severe (>20%) ischemia [13]. It has been shown to reduce angina and relieve symptoms in nearly 70% of patients. [14], lower mortality and need for coronary artery bypass graft (CABG) [14 16] and increase exercise capacity with an improved left ventricular regional and global systolic function indicating the recovery of hibernating myocardium in the territory supplied by the CTO [8,17,14,18 20]. PCI for CTO of the left anterior descending coronary artery (LAD) specifically is associated with improved long-term 5 years survival as compared to PCI failure [21]. Simpler PCI techniques may be successful and safer than complex techniques which are perceived to have high failure rates and technical complexity. Aim of the work To describe the safety and effectiveness of first intentional single wiring and radial approach in the treatment of patients with a CTO of the native LAD at Toulouse Rangueil University Hospitals. Patients and methods J Saudi Heart Assoc The study was a single-center prospective registry. All consecutive patients with a PCI attempt to a native LAD CTO from January to December 2010 were registered. All patients showed evidence of myocardial viability in LAD territory. All other co-existing non-lad coronary lesions indicated for interventional therapy were treated before attempting the CTO procedure (30% of cases within the same session). All cases were first attempts with no previous attempt failures recorded to the specific CTO-LAD vessel. All patients were pretreated and maintained on optimal medical treatment including dual antiplatelet therapy and were able to continue on an antiplatelet agent regimen consisting of aspirin indefinitely and Clopidogrel or Prasugrel daily for at least 6 months after the procedure. The study was approved by the ethical committee of Toulouse University. The study was funded by Toulouse University. All patients included agreed to sign an informed consent for inclusion in the study, all protocols were in compliance with the Declaration of Helsinki. Procedure technique The operators initial strategy was to start by a radial access as a first choice whenever feasible; if not, a femoral access was chosen. Bilateral access was done whenever it was possible to better visualize the distal true lumen through collaterals. Whenever feasible, six French (F) sheathes and catheters were preferred. The decision to perform either an antegrade or a retrograde approach was according to operators discretion dependant on each individual patient s condition. The initial strategy for lesion crossing in either antegrade or

3 J Saudi Heart Assoc NASSAR ET AL 69 retrograde approaches, was single wiring by lesion crossing using only one guidewire (GW) as a simple technique. Multiple wiring by lesion crossing using multiple GWs as complex techniques was chosen when single wiring was not feasible. Lesion success as defined as a final diameter stenosis of <50% with a TIMI three flow. GW crossing success was defined as ability of the GW to cross the occlusion reaching to the distal true lumen. Contrast induced nephropathy (CIN) was defined as either >25% increase of serum creatinine or an absolute increase in serum creatinine (Se Crea) of 0.5 mg/dl after the radiographic examination using a contrast agent. [22]. we avoided injecting 4 6x Crea Clearance to minimize the risk of CIN. Post-procedural MI was defined by post-procedural troponin elevation three times the normal value (0.01 and 0.03 ng/m) [23]. Patients were followed up for radiation dermatitis if X-ray exposure as >300 Gy/cm2. Monitoring of complications included dissection, occlusion of major vessel, occlusion of significant side branch, no reflow, perforation with clinical impact or tamponade, major bleeding, intra aortic balloon counterpulsation, post-procedural infarction (troponin elevation of >3 times normal values), Q-wave myocardial infarction, duration of hospitalization, emergency CABG within 30 days, target vessel revascularization, stroke, or death within 30 days. Statistical Methods Continuous variables were presented as mean + SD or median and range if appropriate. Discrete variables were expressed as counts and percentages. All statistical analyses were performed with JMP version 8.0 (SAS Institute, Cary, North Carolina). The authors had full access to and take full responsibility for the integrity of the data. Results Patients characteristics Between January and December 2010 a total of 30 patients with 30 LAD CTO lesions (100%) were recorded. Mean age was yrs (37% were >80 years old), 77% were males, 23% were females. Cardiovascular risk factors: hypertension was present in 63%, Diabetes 27% (insulin dependent 14%), dyslipidemia 57%, smoking 40%, and hereditary in 13% of patients. Baseline kidney functions showed serum creatinine (Se Crea) within normal ranges in 86% of patients while it was elevated in 14% of patients (Se Crea mean , median 75.5, range lm/l), Crea Clearance was normal in 63% of patients while it was <60 ml/min in 37% of patients (mean , median 86.5, range ml/min), while 3% of patients were known to be maintained on regular dialyses. Duration of hospitalisation was mean days. Underlying coronary lesions Upon initial diagnosis of the LAD-CTO the majority of patients originally were 77% multi-vessel disease while only 23% single vessel disease (CTO-LAD). Coronary artery dominance was right in 86%, left 3%, and co-dominance in 11% of patients. Occlusive lesion Length was <20 mm in 53% and >20 mm in 47% of patients. Collaterals were visible antegradely in 58%, retrogradely in 62%, both antegrade and retrograde in 31% and absent or nonvisible in 7% of patients. Calcification was moderate to severe in 47% of patients. Lesion origin was de novo in 97% and in-stent 3% of patients. Site of lesion was ostial in 7%, proximal 43%, middle in 70% and distal in 13% of patients. The proximal reference artery diam mean mm, median 3, range mm. Bifurcation lesion CTO-diagonal (>1.5 mm) was present in 20% of patients (Table 1). Table 1. Baseline characteristics. Baseline Patient Characteristics Percentage % Males 77 Hypertension 63 Diabetes 27 Dyslipidemic 57 Tobacco 40 Hereditary 13 Coronary Status Upon Diagnosis Bi + Tritruncular 77 Monotruncular 23 Coronary Status before CTO-PCt Bi + Tritruncular 31 Monotruncular 69 Coronary Dominance Rght dominance 86 Left dominance 3 Co dominance 10 Calcification Mild 47 Moderate 30 Severe 17 Site of CTO in LAD Ostial 7 Proximal 43 Midsegment 70 Distal 13

4 70 NASSAR ET AL Access route The radial route was accessed in 66% of patients (single radial 36%, double radial-radial 10). The femoral route was accessed in 54% of patients (single femoral 24%, double femoral-femoral 10%). A double radial-femoral was accessed in 20% of patients (Figure 1). Sheaths and catheters of size 6F were used in 53% while size 7F were used in 73% of patients. No 8F sheaths were used. Microcatheters were used in 66% of patients (Finecross 56%, Corsair 10%) representing 55% of antegrade and 100% of retrograde procedures. Figure 2. Approach. J Saudi Heart Assoc Figure 3. Total outcome. Overall outcome An initial antegrade approach was attempted in 80% of cases while initial retrograde approach was attempted in 20% of cases. In antegrade approaches, 97% of lesions were attempted with single wiring and 3% by multiple wiring techniques. Retrograde approaches were all attempted with single wiring (100%) through visible septal collaterals (100%) without attempts through epicardial collaterals (0%) (Figure 2). GW crossing success occurred in 93% of the total cases (92% of antegrade and 67% of retrograde approaches). GW types achieving successful crossing showed a 44% majority of soft tapered GWs, 36% soft non-tapered, 16% stiff non-tapered GWs, and 4% of stiff tapered GWs. Overall Lesion Success (final diameter stenosis < 50% with TIMI3 flow) occurred in 83% of total cases (81% in antegrade and 67% in retrograde approaches respectively). The cause of failure in total patients was balloon crossing failure or dissection (10%) followed by wire crossing failure (7%). In antegrade cases, balloon crossing failure and dissection (12%) and wire crossing failure (7%). The only cause of failure for retrograde approach was collateral wire crossing failure (33%) (Figure 3). Successful cases were finalized with conventional stenting (83%). Kissing with provisional T-stenting was done in 67% for bifurcational diagonal side branch CTOs, while 33% of cases stenting without kissing. Anchoring in a side branch septal or diagonal to facilitate stent delivery was done in 6% of patients. Rotablateur 3%, IVUS 3%, and Tornus 3% were used to facilitate the procedure with success, and all were with antegrade approaches. Thirty- day Complications Contrast induced Nephropathy (Post procedural Creatinine elevation >25%) was reported in 7% of total cases. Post-procedural MI (Troponin >3 Figure 1. Access routes.

5 J Saudi Heart Assoc NASSAR ET AL 71 Figure 4. Complications. times normal value) occurred in 30% of patients. Occlusion in a major vessel occurred in 3%, occlusion of side-branch 3%, dissection in major vessel 3%, dissection in side-branch 7%, transient no-reflow 3%, and intra-aortic counterpulsation 3%. No events were recorded for Q-wave MI 0%, cerebrovascular stroke 0%, stent thrombosis or target vessel revascularisation 0%, major bleeding 0%, perforation with clinical impact or tamponade 0%, CABG within 30 days 0%, while one patient (3%) was referred to CABG scheduled after 30 days. Death occurred in one patient (3%) who was an 83 year old male with multivessel disease unfit for surgery, recorded as refractory cardiorespiratory arrest in the intensive care after an apparently angiographically successful procedure (Figure 4). Discussion Owing to the ongoing evolution in dedicated materials and techniques of PCI to CTOs during the past decade, success rates jumped from 51% in the balloon angioplasty era to 70% in the DES era [24] and 86.6% in experienced hands after patient selection [25] The choice of the most simple technique and the smallest sizes of invasive catheter materials by a radial access may be a safe and effective strategy to obtain a good success rate and lower adverse events or complications. Patient characteristics in our study showed a high incidence of diabetes (27%) consistent with reports showing diabetes (22%) [26] and (43%) [25]. Chronic dialysis in our study was (3%) comparable to other reports showing (4%) [25] The underlying coronary lesion was single vessel disease in 23% of our patients, while in other reports was 28.9% [27] and 28.8% [26] were single vessel disease, and the rest of the patients had multi-vessel disease. Our study involved LAD CTO lesions in all patients (100%) while in other registries it was 36% [25] and 31% [26]. In our study 97% were de novo lesions of native LAD comparable to the other registries 93.8% [26] and 93.7% [25] Bifurcation lesion CTO-diagonal (>1.5 mm) was present in 20% of our patients versus 16% in other reports (28 Rathore et al. 2009). Proximal reference artery diameter in our patients mean was versus mm in the J-CTO Registry [25]. Access route in our study was predominantly radial 66%, femoral 54% versus femoral 87% and radial in only 8% in the J-CTO Registry [25]. Double access and contralateral injection in our study occurred in 40% of total patients versus 62% according to the Euro-CTO Club Consensus [2] and 70% in the J-CTO Registry [25]. Sheaths and catheters sizes used in our study were composed of size 6F in 53%, 7F in 73% of patients, while no 8F was used in any patient (0%) versus 6F in just 10%, 7F in 82% and 8F in7% in the J-CTO Registry [25]. There is a general consensus that the use of 6F catheters are probably sufficient for more straightforward CTOs while in the most complex lesions only 7F guiding catheters are sufficiently large to advance two wires and two OTW catheters (micro-catheters) for parallel wire technique [2]. The isolated GW success rate in our study was 93% in total cases comparative to 87.7% in the J-CTO Registry [25] Overall lesion success rate in our study was 83% of lesions, in comparison to the high records of 86.2% success rate in the CONQUEST registry [28] and the 86.6% success rate of the J- CTO registry [25]. Lesion success rate of primary antegrade procedures was 79% in our study versus 74% of the J-CTO Registry [25]. On the other hand,

6 72 NASSAR ET AL lesion success rate of primary retrograde procedures was 67% in our study versus the relatively high 79.2% of the J-CTO Registry [25]. Single wiring was the prevailing technique in our study being used in 97% of successful lesions (83% of total cases) versus 50% single wiring in the J- CTO Registry [25], while only 3% were by multiple wiring techniques. Successful single antegrade wiring represented 63% of our total study cases with a GW success rate of 92% of cases versus 55.5% with a GW success rate of 91.8% in the J-CTO Registry [25]. Successful single retrograde wiring represented 13% of our total study cases with a GW success rate of 67% versus 12.4% of cases with a GW success rate of 84.5% in the J-CTO Registry [25]. Lesion failure due to GW crossing failure occurred in 7%, while lesion failure due to balloon crossing failure and/or dissection occurred in 10% of cases. In the antegrade approach, balloon crossing failure and dissection (12%) and wire crossing failure (7%). In the retrograde approach, collateral wire crossing failure was the only cause of lesion failure (33%). GW crossing failure was the most common cause of CTO lesion failure according to the Euro-CTO Club Consensus [2]. Complications Cardiac death was seen in 3% of the patients in our study, while it was seen only in 0.2% of cases of the J-CTO Registry [25]. This apparent difference is probably due to the relative small number of cases. Cardiac tamponade or clinical perforation requiring any hemostatic maneuvers was not found in our study (0%), as with the J-CTO registry which was strikingly low at 0.4%, compared with the previous reports (a range of 0.8% to 1.9%) [24,28]. In their case, the balloon tamponade was sufficient to seal it with heparin reversal in the J-CTO Registry [25]. Post procedural Troponin 3x normal occurred in 30% of patients in our study. The high incidence of post-procedural elevation of highly sensitive Troponin may be an overestimation of peri-procedural infarction and not correlating with clinical symptoms. A TnT more than three times the 99th percentile has been proven to occur in 27% of low risk procedure patients [31], and CK-MB in that case may be more clinically relevant [29] Recently, the third universal definition of myocardial infarction declared that myocardial infarction associated with PCI is arbitrarily defined by elevation of ctn values >5x 99th percentile URL in patients with normal baseline values [32] Contrast induced nephropathy incidence in our study was 7% in the non-hd patients while it was unexpectedly low (1.2%) in the J-CTO Registry [25]. The contrast volume was below 4x Crea Clearance in 68% of patients, and approximately 5x creatinine clearance in 32% of patients, and never exceeded 6x Crea Clearance value (0%). A V/CrCl ratio 3.7 was a significant and independent predictor of an early abnormal increase in serum creatinine after PCI. [30]. Reduction of contrast volume might be achieved by marker retrograde GWs and super-selective injections from the collateral channel using a micro-catheter. Q-wave MI was not recorded in our study (0%) compared to (0.24%) in the J-CTO Registry. [25] There was no stroke (0%), stent thrombosis (0%), emergency CABG, major bleeding (0%) or Radiation Dermatitis (0%) during the hospital stay. This is comparable to the rare occurrence of any significant in-hospital complications, emergent CABG, access site surgery, and gastrointestinal bleeding in the J-CTO Registry [25] Limitations The numbers of cases are small and are from a single center. The results of this study could be influenced by selection criteria, operator skills, judgment, individual experience in varying techniques.there is a lack of follow-up beyond 30 days. Finally, the techniques are still in continuous evolution and newer devices and techniques were introduced during the course of the study. Three patient s data of materials documentation used in the cath lab were not retrievable. Conclusion Single wiring and radial access as initial strategies in PCI for LAD-CTO lesions in either approaches antegrade or retrograde are associated with a high procedural success rate and an acceptable incidences of adverse events. References J Saudi Heart Assoc [1] Stone GW, Kandzari DE, Mehran R, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation 2005;112: [2] Di Mario C, Werner GS, Sianos G, Galassi AR, Büttner J, Dudek D, Chevalier B, Lefevre T, Schofer J, Koolen J, Sievert H, Reimers B, Fajadet J, Colombo A, Gershlick A, Serruys PW, Reifart N. Perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club.EuroIntervention May; 3(1): [3] Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH, Christofferson RD, et al. Effect of chronic total occlusion on treatment strategy. Am J Cardiol 2005;95: [4] Srivatsa SS, Edwards WD, Boos CM, Grill DE, Sangiorgi GM, Garratt KN, et al. Histologic correlates of angiographic chronic total coronary artery occlusions:

7 J Saudi Heart Assoc NASSAR ET AL 73 influence of occlusion duration on neovascular channel patterns and intimal plaque composition. J Am Coll Cardiol 1997;29: [5] Werner GS, Ferrari M, Betge S, Gastmann O, Richartz BM, Figulla HR. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation 2001;104: [6] Werner GS, Figulla HR. Direct assessment of coronary steal and associated changes of collateral hemodynamics in chronic total coronary occlusions. Circulation 2002;106: [7] Werner GS, Fritzenwanger M, Prochnau D, Schwarz G, Ferrari M, Aarnoudse W, et al. Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance. J Am Coll Cardiol 2006;48:51 8. [8] Werner GS, Surber R, Kuethe F, Emig U, Schwarz G, Bahrmann P, et al. Collaterals and the recovery of left ventricular function after Recanalization of a chronic total coronary occlusion. Am Heart J 2005;149: [9] Surber R, Schwarz G, Figulla HR, Werner GS. Resting 12- lead electrocardiogram As a reliable predictor of functional recovery after recanalization of chronic total coronary occlusions. A thorough non-invasive investigation before treatment is highly recommended to establish the presence of ischaemia and viability in the territory of the chronically occluded artery. Clin Cardiol 2005;28: [10] Claessen BE et al. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. JACC Cardiovasc Interv 2009;2(11): [11] Moreno R, Conde C, Perez-Vizcayno MJ, Villarreal S, Hernandez-Antolin R, Alfonso F, et al. Macaya C Prognostic impact of a chronic occlusion in a noninfarct Vessel in patients with acute myocardial infarction and multivessel disease Undergoing primary percutaneous coronary intervention. J Invasive Cardiol 2006;18:16 9. [12] Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008 Mar 11;117(10): Epub 2008 Feb 11. [13] Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003 Jun 17;107(23): Epub 2003 May 27. [14] Suero J, Marso SP, Jones PG, Later SB, Huber KC, Giorgi LV, et al. Procedural outcomes and long term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20 year experience. J Am Coll Cardiol 2001;38: [15] Hoye A, Aoki J, van Mieghem C, Rodriguez-Granillo G, Valgimigli M. Drug eluting stent implantation for chronic total occlusions: comparison between the sirolimus and paclitaxel eluting stent. Eurointervention 2005;2: [16] Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions: a systematic review and metaanalysis. Am Heart J 2010;160: [17] Melchior JP, Doriot PA, Chatelain P, Meier B, Urban P, Finci L, et al. Improvement of left ventricular contraction and relaxation synchronism after recanalization of chronic total coronary occlusion by angioplasty. J Am Coll Cardiol 1987;9: [18] Olivari Z, Rubartelli P, Piscione F, et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol 2003;41: [19] Finci L, Meier B, Favre J, Righetti A, Rutishauser W. Longterm results of successful and failed angioplasty for chronic total coronary arterial occlusion. Am J Cardiol 1990;66: [20] Sirnes PA, Myreng Y, Molstad P, Bonarjee V, Golf S. Improvement In left ventricular ejection fraction and wall motion after successful recanalization of chronic coronary occlusions. Eur Heart J 1998;19: [21] Safley David M, House John A, Marso Steven P, Aaron Grantham J, Rutherford Barry D. Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel free. J Am Coll Cardiol Intv 2008;1(3): doi: /j.jcin [22] Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006;354: [23] Abhiram Prasad, Joerg Herrmann. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med 2011;364: [24] Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes Jr DR. Trends in outcomes after percutaneous coronary intervention of chronic Total occlusions: a 25 year experience from Mayo clinic. J Am Coll Cardiol 2007;49: [25] Morino Y et al. J-CTO registry, in-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion. J Am Coll Cardiol Intv 2010;3: [26] Héctor M, García-García, Neville Kukreja, Joost Daemen, Shuzou Tanimoto, Carlos van Mieghem, et al. Contemporary treatment of patients with chronic total occlusion: critical appraisal of different state-of-the-art techniques and devices. Eurointervention 2007;3: [27] Rathore S, Katoh O, Matsuo H, Terashima M, Tanaka N, Kinoshita Y, et al. Retrograde percutaneous recanalization of chronic total occlusion of the coronary arteries: procedural outcomes and predictors of success in contemporary practice. Circ Cardiovasc Interv 2009 Apr;2(2): Epub 2009 Feb 20. [28] Mitsudo K, Yamashita T, Asakura Y, et al. Recanalization strategy for chronic total occlusions with tapered and stifftip guidewire. The results of CTO New technique for standard procedure (CONQUEST) trial. J Invasive Cardiol 2008;20: [29] Chris CS, Lim, William J, Van Gaal, LucaTesta, Florim Cuculi, et al. Banning with the Universal Definition, measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. J Am Coll Cardiol 8 February 2011;57(6): [30] Laskey Warrenk. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007;50(7): [31] Alcock RF, Roy P, Adorini K, Lau GT, Kritharides L, Lowe HC, et al. Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation. Int J Cardiol 2010 Apr 1;140(1): [32] Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Eur Heart J 2012;33:

Clinical Considerations for CTO

Clinical Considerations for CTO 38 RCTs Clinical Considerations for CTO 18,000 pts Revascularization Whom to treat, Who derives benefit and What can we achieve? David E. Kandzari, MD FACC, FSCAI Director, Interventional Cardiology Research

More information

Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe?

Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe? Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe? T. Lefèvre,, Massy, France Background Despite continuous improvement, PTCA of chronic total occlusion remains a real technical challenge.

More information

Prognostic factors in primary and elective percutaneous coronary intervention Claessen, B.E.P.M.

Prognostic factors in primary and elective percutaneous coronary intervention Claessen, B.E.P.M. UvA-DARE (Digital Academic Repository) Prognostic factors in primary and elective percutaneous coronary intervention Claessen, B.E.P.M. Link to publication Citation for published version (APA): Claessen,

More information

Outcome of Successful Versus Unsuccessful Percutaneous Coronary Intervention in Chronic Total Occlusions in One Year Follow-Up

Outcome of Successful Versus Unsuccessful Percutaneous Coronary Intervention in Chronic Total Occlusions in One Year Follow-Up Elmer Press Original Article Outcome of Successful Versus Unsuccessful Percutaneous Coronary Intervention in Chronic Total Occlusions in One Year Follow-Up Bahram Sohrabi a, Samad Ghaffari a, Afshin Habibzadeh

More information

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Chronic Total Occlusions Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Financial Disclosures /see -tee-oh / abbr. Med. Chronic Total Occlusion,

More information

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / / Patient Patient code Birth date: / / Sex: Male Height (cm): Female Weight (kg): Risk Factors: Family history of coronary disease: Hypertension Dyslipidemia Peripheral disease Diabetes Comorbidities: No

More information

Chronic Total Occlusion: A case for coronary artery bypass grafting

Chronic Total Occlusion: A case for coronary artery bypass grafting Chronic Total Occlusion: A case for coronary artery bypass grafting Prof. Alfredo R Galassi MD, FESC, FACC, FSCAI Director of Cardiac Catheterization and Interventional Cardiology Unit Department of Medical

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

For Personal Use. Copyright HMP 2013

For Personal Use. Copyright HMP 2013 Case Report J INVASIVE CARDIOL 2013;25(2):E39-E41 A Case With Successful Retrograde Stent Delivery via AC Branch for Tortuous Right Coronary Artery Yoshiki Uehara, MD, PhD, Mitsuyuki Shimizu, MD, PhD,

More information

CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION

CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION *Bimmer Claessen, Loes Hoebers, José Henriques Department of Cardiology, Academic Medical Center, University of Amsterdam,

More information

Clinical Considerations for CTO Revascularization

Clinical Considerations for CTO Revascularization Clinical Considerations for CTO Revascularization Whom to treat, Who derives benefit and What can we achieve? David E. Kandzari, MD, FACC, FSCAI Chief Medical Officer Cordis Cardiology Johnson & Johnson

More information

Complication management and long-term outcome after percutaneous coronary intervention

Complication management and long-term outcome after percutaneous coronary intervention Complication management and long-term outcome after percutaneous coronary intervention ESC meeting 2012, Munich, Germany Session: Chronic total occlusion: a challenge for percutaneous coronary intervention

More information

PCI TO CHRONIC TOTAL OCCLUSION, LIAQUAT NATIONAL HOSPITAL EXPERINCE

PCI TO CHRONIC TOTAL OCCLUSION, LIAQUAT NATIONAL HOSPITAL EXPERINCE SUMMARY PCI TO CHRONIC TOTAL OCCLUSION, LIAQUAT NATIONAL HOSPITAL EXPERINCE INTRODUCTION GHAZALA IRFAN*, MANSOOR AHMAD**, DAD JAN BALOCH @, ABDUL RASHEED @@ BACKGROUND PCI of chronic total occlusion represents

More information

Chronic Total Occlusion: a case for coronary artery bypass grafting

Chronic Total Occlusion: a case for coronary artery bypass grafting Chronic Total Occlusion: a case for coronary artery bypass grafting Rune Haaverstad Professor & Chief Dept. of Cardiothoracic Surgery Haukeland University Hospital Bergen, Norway Disclosure Research cooperation

More information

Antegrade techniques for CTO recanalization. Dr. George Karavolias, MD, PhD, FESC, FACC Interventional Cardiologist

Antegrade techniques for CTO recanalization. Dr. George Karavolias, MD, PhD, FESC, FACC Interventional Cardiologist Antegrade techniques for CTO recanalization Dr. George Karavolias, MD, PhD, FESC, FACC Interventional Cardiologist can CTOs be reliably opened by PCI? Meta-Analysis of 18,061 Patients Patel V, J Am Coll

More information

Coronary interventions

Coronary interventions Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF

More information

STEMI AND MULTIVESSEL CORONARY DISEASE

STEMI AND MULTIVESSEL CORONARY DISEASE STEMI AND MULTIVESSEL CORONARY DISEASE ΤΣΙΑΦΟΥΤΗΣ Ν. ΙΩΑΝΝΗΣ ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Α ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣ ΕΡΥΘΡΟΥ ΣΤΑΥΡΟΥ IRA 30-50% of STEMI patients have additional stenoses other than the infarct related

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

SUCCESS RATE OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION OF CORONARY ARTERIES

SUCCESS RATE OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION OF CORONARY ARTERIES SUCCESS RATE OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION OF CORONARY ARTERIES Mashallah Dehghani (1), Homa Falsoleiman (2), Sayed Mohammad Reza Moosavi (3) Abstract BACKGROUND:

More information

Illustration of the hybrid approach to chronic total occlusion crossing

Illustration of the hybrid approach to chronic total occlusion crossing case report Illustration of the hybrid approach to chronic total occlusion crossing The hybrid approach to coronary chronic total occlusions advocates using all feasible crossing techniques in a manner

More information

PCI for Chronic Total Occlusions

PCI for Chronic Total Occlusions PCI for Chronic Total Occlusions Chronic Total Occlusions 20-40% of patients with CAD Why should we open? Rationale for CTO Revascularization Relief of symtomatic ischemia and angina Increase long-term

More information

Bifurcation stenting with BVS

Bifurcation stenting with BVS Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have

More information

Clinical, Electrocardiographic, and Procedural Characteristics of Patients With Coronary Chronic Total Occlusions

Clinical, Electrocardiographic, and Procedural Characteristics of Patients With Coronary Chronic Total Occlusions ORIGINAL ARTICLE DOI 10.4070 / kcj.2009.39.3.111 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Clinical, Electrocardiographic, and Procedural Characteristics

More information

Significant Reduction in Restenosis After the Use of Sirolimus-Eluting Stents in the Treatment of Chronic Total Occlusions

Significant Reduction in Restenosis After the Use of Sirolimus-Eluting Stents in the Treatment of Chronic Total Occlusions Journal of the American College of Cardiology Vol. 43, No. 11, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.01.045

More information

CTO Re vascularization in 2013

CTO Re vascularization in 2013 CTO Re vascularization in 2013 Is it safe to use/stent the sub intimal space? Dimitri Karmpaliotis, MD, FACC, FSCAI Interventional Cardiology Piedmont Heart Institute Atlanta, Georgia Dimitri.karmpaliotis@piedmont.org

More information

Percutanous revascularization of chronic total occlusion of diabetic patients at Iraqi center for heart diseases, a single center experience 2012

Percutanous revascularization of chronic total occlusion of diabetic patients at Iraqi center for heart diseases, a single center experience 2012 www.muthjm.com Muthanna Medical Journal 2015; 2(2):76-82 Percutanous revascularization of chronic total occlusion of diabetic patients at Iraqi center for heart diseases, a single center experience 2012

More information

Retrograde Coronary Chronic Total Occlusion Revascularization

Retrograde Coronary Chronic Total Occlusion Revascularization JACC: CARDIOVASCULAR INTERVENTIONS VOL. 5, NO. 12, 2012 2012 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcin.2012.06.025

More information

Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut

Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut Adjunct Professor Emory University School of Medicine Indication

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Anatomical, physiological and clinical relevance of a side branch

Anatomical, physiological and clinical relevance of a side branch Anatomical, physiological and clinical relevance of a side branch : Which branch really needs a stent? Bon-Kwon Koo, MD, PhD, Seoul, Korea Bifurcation lesion: The GREAT EQUALIZER! No intervention = Balloon

More information

Educational Objectives. Conflict of Interest Disclosure. TIMI Flow Classification TIMI= Thrombolysis in Myocardial Infarction TIMI 0 Flow

Educational Objectives. Conflict of Interest Disclosure. TIMI Flow Classification TIMI= Thrombolysis in Myocardial Infarction TIMI 0 Flow Educational Objectives Percutaneous Coronary Interventions (PCI) in Chronic Total Occlusions (CTO s) The Last Frontier Ramon L. Lloret, MD, FACC, FSCAI At the end of this talk, attendees will: Understand

More information

J. Schwitter, MD, FESC Section of Cardiology

J. Schwitter, MD, FESC Section of Cardiology J. Schwitter, MD, FESC Section of Cardiology CMR Center of the CHUV University Hospital Lausanne - CHUV Switzerland Centre de RM Cardiaque J. Schwitter, MD, FESC Section of Cardiology CMR Center of the

More information

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease

More information

Masashi Kimura, MD Etsuo Tsuchikane, MD Osamu Katoh, MD Toyohashi Heart Center, Japan

Masashi Kimura, MD Etsuo Tsuchikane, MD Osamu Katoh, MD Toyohashi Heart Center, Japan Masashi Kimura, MD Etsuo Tsuchikane, MD Osamu Katoh, MD, Japan Retrograde Approach for Coronary CTO Collateral channels A. bypass graft B. epicardial collateral C. septal perforator Retrograde wiring techniques

More information

Can a Penetration Catheter (Tornus) Substitute Traditional Rotational Atherectomy for Recanalizing Chronic Total Occlusions?

Can a Penetration Catheter (Tornus) Substitute Traditional Rotational Atherectomy for Recanalizing Chronic Total Occlusions? Clinical Studies Can a Penetration Catheter (Tornus) Substitute Traditional Rotational Atherectomy for Recanalizing Chronic Total Occlusions? Hsiu-Yu Fang, 1* MD, Chih-Yuan Fang, 1* MD, Hisham Hussein,

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

FFR-guided Jailed Side Branch Intervention

FFR-guided Jailed Side Branch Intervention FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still

More information

Percutaneous Coronary Intervention (PCI) in Patients with Chronic Total Occlusion (CTO): A Single Center Experiences

Percutaneous Coronary Intervention (PCI) in Patients with Chronic Total Occlusion (CTO): A Single Center Experiences Percutaneous Coronary Intervention (PCI) in Patients with Chronic Total Occlusion (CTO): A Single Center Experiences AHMW Islam, S Munwar, S Talukder, AQM Reza Dept. of Interventional and Invasive Cardiology,

More information

Zahoor Aslam Khattak, Nadir Khan, Muhammad Qaisar Khan, Naseer Ahmed Samore, Adeel, Sohail Aziz

Zahoor Aslam Khattak, Nadir Khan, Muhammad Qaisar Khan, Naseer Ahmed Samore, Adeel, Sohail Aziz Original Article Pak Armed Forces Med J 2015; 65(Suppl): S48-52 PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC TOTAL OCCLUSION: EXPERIENCE AT ARMED FORCES INSTITUTE OF CARDIOLOGY Zahoor Aslam Khattak,

More information

Chronic Total Occlusions (CTO): The Final Fron er of Coronary Interven on CTO PCI

Chronic Total Occlusions (CTO): The Final Fron er of Coronary Interven on CTO PCI Chronic Total Occlusions (CTO): The Final Fron er of Coronary Interven on Christopher D. Nielsen, M.D. Director, Adult Cardiac Cath Labs Medical University of South Carolina CTO PCI What is a CTO and how

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

PCI for Chronic Total Occlusions

PCI for Chronic Total Occlusions PCI for Chronic Total Occlusions Chronic Total Occlusions Why not Medical Treatment? Medical Treatment CTO in 891 pts over 24 years High 10% Mortality Low 2 % 1 year 10 years Puma JA, et al. JACC 1994;23:390A

More information

CHRONIC TOTAL OCCLUSION IN PATIENTS AFTER CORONARY ARTERY BYPASS GRAFTING: A REVIEW OF POSSIBLE INTERVENTIONS AND RESULTS WITH A CASE STUDY

CHRONIC TOTAL OCCLUSION IN PATIENTS AFTER CORONARY ARTERY BYPASS GRAFTING: A REVIEW OF POSSIBLE INTERVENTIONS AND RESULTS WITH A CASE STUDY CHRONIC TOTAL OCCLUSION IN PATIENTS AFTER CORONARY ARTERY BYPASS GRAFTING: A REVIEW OF POSSIBLE INTERVENTIONS AND RESULTS WITH A CASE STUDY *Sergey N. Furkalo Department of Endovascular Surgery and Angiography,

More information

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy STENTYS for Le, Main Sten2ng Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement or affilia2on

More information

Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic

Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) J. D. Abbott, et al. Am J Cardiol (2007) 99;626-31

More information

Hospital, 6 Lukon Road, Lukong Town, Changhua Shien, Taiwan 505, Taiwan.

Hospital, 6 Lukon Road, Lukong Town, Changhua Shien, Taiwan 505, Taiwan. Volume 1, Issue 1 Image Article Resolution of Inferior Wall Ischemia after Successful Revascularization of LAD Lesion: The Value of Myocardial Perfusion Imaging in Guiding Management of Multi-vessel CAD

More information

J aborde toute les CTO.

J aborde toute les CTO. J aborde toute les CTO. Quand le territoire est viable et ischémique Thierry Lefèvre Prévalence des CTOs Patients 18% 54% 10% Fefer P et al. J Am Coll Cardiol. 2012;59:991- What do we currently know? 1.

More information

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Le# main treatment with Stentys stent Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement

More information

Current Perspectives on Coronary Chronic Total Occlusions

Current Perspectives on Coronary Chronic Total Occlusions Journal of the American College of Cardiology Vol. 59, No. 11, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.12.007

More information

Hybrid algorithm for chronic total occlusion percutaneous coronary intervention

Hybrid algorithm for chronic total occlusion percutaneous coronary intervention SPECIAL FOCUS y Chronic total occlusions commentary Hybrid algorithm for chronic total occlusion percutaneous coronary intervention The emphasis [of the hybrid approach] is on procedural efficiency, recommending

More information

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao) The Microport FIREBIRD Polymer-based Sirolimus- Eluting Stent Clinical Trial Program Update: The FIC and FIREMAN Registries Junbo Ge, MD, FACC, FESC, FSCAI On behalf of Runlin Gao (FIC PI) and Haichang

More information

Trattamento delle CTO Indicazioni e risultati

Trattamento delle CTO Indicazioni e risultati Trattamento delle CTO Indicazioni e risultati Prof. Alfredo R. Galassi MD, FESC, FACC, FSCAI Department of Medical Sciences and Pediatrics, University of Catania, Italy and University Heart Center, University

More information

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional

More information

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT01724957 Dobrin Vassilev MD, PhD Assoc. Prof. in Cardiology Head Cardiology Clinic, Alexandrovska University Hospital Medical

More information

BSIC, Manchester, September 15, Gerald S. Werner, MD, FESC, FACC Klinikum Darmstadt, Germany

BSIC, Manchester, September 15, Gerald S. Werner, MD, FESC, FACC Klinikum Darmstadt, Germany BSIC, Manchester, September 15, 2006 Gerald S. Werner, MD, FESC, FACC Klinikum Darmstadt, Germany BSIC, Manchester, September 15, 2006 Chronic total occlusions update A European perspective Gerald S. Werner,

More information

Lessons learned From The National PCI Registry

Lessons learned From The National PCI Registry Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients

More information

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

Interventional Cardiology

Interventional Cardiology Interventional Cardiology Retrograde approach to successfully treat antegrade failure due to subintimal hematoma of a right coronary artery chronic total occlusion Use of antegrade dissection re-entry

More information

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 Igor F. Palacios, MD Director of Interventional Cardiology Professor of Medicine Massachusetts

More information

DECISION - CTO. optimal Medical Treatment in patients with. Seung-Jung Park, MD, PhD, FACC for the DECISION-CTO Study investigators

DECISION - CTO. optimal Medical Treatment in patients with. Seung-Jung Park, MD, PhD, FACC for the DECISION-CTO Study investigators DECISION - CTO Drug-Eluting stent Implantation versus optimal Medical Treatment in patients with ChronIc Total OccluSION Seung-Jung Park, MD, PhD, FACC for the DECISION-CTO Study investigators Asan Medical

More information

Modified Reverse CART technique in a near-ostial

Modified Reverse CART technique in a near-ostial Modified Reverse CART technique in a near-ostial RCA CTO Dr. Vincent O.H. Kwok MB BS (HK) FRCP (Lond( Lond, Edin, Glasg) ) FACC FSCAI Consultant Cardiologist & Director Cardiac Catheterization & Intervention

More information

Interventional Cardiology

Interventional Cardiology Interventional Cardiology Volume 7 Issue 1 Spring 2012 Extract Post-coronary Artery Bypass Grafting Degenerated Saphenous Vein Graft Intervention, or Native Vessel Coronary Chronic Total Occlusion Recanalisation?

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

The Case for Multivessel Revascularization in Shock

The Case for Multivessel Revascularization in Shock The Case for Multivessel Revascularization in Shock Emmanouil S. Brilakis, MD, PhD Minneapolis Heart Institute 9.37 9.49 am Disclosures Consulting/speaker honoraria: Abbott Vascular, American Heart Association

More information

Side Branch Occlusion

Side Branch Occlusion Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion

More information

Post-Procedural Myocardial Injury or Infarction

Post-Procedural Myocardial Injury or Infarction Post-Procedural Myocardial Injury or Infarction Hugo A Katus MD & Evangelos Giannitsis MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Conflict of Interest:

More information

Topic. Updates on Definition of Myocardial Infarction

Topic. Updates on Definition of Myocardial Infarction Topic Updates on Definition of Myocardial Infarction In the past, general consensus for MI? Definition of MI by WHO - Combination of 2 of 3 characteristics - 1. Typical Symptoms 2. Enzyme Rise 3. Typical

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

FFR Incorporating & Expanding it s use in Clinical Practice

FFR Incorporating & Expanding it s use in Clinical Practice FFR Incorporating & Expanding it s use in Clinical Practice Suleiman Kharabsheh, MD Consultant Invasive Cardiology Assistant professor, Alfaisal Univ. KFHI - KFSHRC Concept of FFR Maximum flow down a vessel

More information

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System Volume 1, Issue 1 Case Report Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System Robert F. Riley * and Bill Lombardi University of Washington Medical Center, Division

More information

Current evidence base for chronic total occlusion revascularization

Current evidence base for chronic total occlusion revascularization SPECIAL FOCUS y Chronic total occlusions review Current evidence base for chronic total occlusion revascularization Coronary chronic total occlusion (CTO) accounts for an increasing proportion of referrals

More information

Ping-Pong Guide Catheter Technique for Retrograde Intervention of a Chronic Total Occlusion Through an Ipsilateral Collateral

Ping-Pong Guide Catheter Technique for Retrograde Intervention of a Chronic Total Occlusion Through an Ipsilateral Collateral Catheterization and Cardiovascular Interventions 78:395 399 (2011) Case Reports Ping-Pong Guide Catheter Technique for Retrograde Intervention of a Chronic Total Occlusion Through an Ipsilateral Collateral

More information

Final Kissing Ballooning Returns? The analysis of COBIS II registry

Final Kissing Ballooning Returns? The analysis of COBIS II registry Final Kissing Ballooning Returns? The analysis of COBIS II registry Hyeon- Cheol Gwon Heart Vascular & Stroke Ins?tute, Samsung Medical Center Sungkyunkwan University School of Medicine Final Kissing Ballooning

More information

Protection of side branch is essential in treating bifurcation lesions: overview

Protection of side branch is essential in treating bifurcation lesions: overview Angioplasty Summit TCT Asia Pacific Seoul, April 26-28, 2006 Protection of side branch is essential in treating bifurcation lesions: overview Alfredo R Galassi, MD, FACC, FSCAI, FESC Head of the Catetherization

More information

Stent Thrombosis in Bifurcation Stenting

Stent Thrombosis in Bifurcation Stenting Summit TCT Asia Pacific 2009 Stent Thrombosis in Bifurcation Stenting Associate Professor Tan Huay Cheem MBBS, M Med(Int Med), MRCP, FRCP(UK), FAMS, FACC, FSCAI Director, National University Heart Centre,

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Belinda Green, Cardiologist, SDHB, 2016

Belinda Green, Cardiologist, SDHB, 2016 Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens

More information

Breakage and retention of wire fragments

Breakage and retention of wire fragments Case Report Hellenic J Cardiol 2011; 52: 79-83 Septal Wire Entrapment During Recanalisation of a Chronic Total Occlusion with the Retrograde Approach Georgios Sianos, Michail I. Papafaklis 1st Cardiology

More information

The Role of the Retrograde Approach in Percutaneous Coronary Interventions for Chronic Total Occlusions : Insights from the Japanese Retrograde

The Role of the Retrograde Approach in Percutaneous Coronary Interventions for Chronic Total Occlusions : Insights from the Japanese Retrograde Interventional Cardiology The Role of the Retrograde Approach in Percutaneous Coronary Interventions for Chronic Total Occlusions : Insights from the Japanese Retrograde Summit Registry Background: Percutaneous

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

PCI for Long Coronary Lesion

PCI for Long Coronary Lesion PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2

More information

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ".

Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique . Complex PCI of an LAD/Diagonal bifurcation lesion (Medina 1,1,1) utilizing the DK Crush technique ". "Σύμπλοκη αγγειοπλαστική βλάβης διχασμού LAD/Diagonal (Medina 1,1,1) με την τεχνική DK crush ". Anastasios

More information

Chronic total occlusion occurs in 10% of patients with

Chronic total occlusion occurs in 10% of patients with Off-Pump Revascularization of Chronically Occluded Left Anterior Descending Artery Through Left Anterior Small Thoracotomy: Early and Late Angiographic and Clinical Follow-Up Gabriele Di Giammarco, MD,

More information

Evaluating Clinical Risk and Guiding management with SPECT Imaging

Evaluating Clinical Risk and Guiding management with SPECT Imaging Evaluating Clinical Risk and Guiding management with SPECT Imaging Raffaele Giubbini Chair and Nuclear Medicine Unit University & Spedali Civili Brescia- Italy U.S. Congressional Budget Office. Technological

More information

Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery. Christian Seiler No conflict of interest to declare.

Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery. Christian Seiler No conflict of interest to declare. Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery Christian Seiler No conflict of interest to declare PCI Long-Term Outcome Perioperative Management After Coronary Stenting:

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Rationale for Percutaneous Revascularization ESC 2011

Rationale for Percutaneous Revascularization ESC 2011 Rationale for Percutaneous Revascularization Marie Claude Morice, Massy FR MD, FESC, FACC ESC 2011 Paris Villepinte - 27-31 August, 2011 Massy, France Potential conflicts of interest I have the following

More information

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Acute Myocardial Infarction. Willis E. Godin D.O., FACC Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable

More information

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,

More information

Clinical Investigations

Clinical Investigations Clinical Investigations Clinical Outcomes for Single Stent and Multiple Stents in Contemporary Practice Qiao Shu Bin, MD; Liu Sheng Wen, MD; Xu Bo, BS; Chen Jue, MD; Liu Hai Bo, MD; Yang Yue Jin, MD; Chen

More information

Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention

Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary

More information

Contemporary therapy of bifurcation lesions

Contemporary therapy of bifurcation lesions Contemporary therapy of bifurcation lesions Dr Angela Hoye MB ChB PhD MRCP Interventional Cardiologist Kingston-upon-Hull, UK Hull The challenge of bifurcations Risk of peri-procedural infarction Relatively

More information

Perspective of LM stenting with Current registry and Randomized Clinical Data

Perspective of LM stenting with Current registry and Randomized Clinical Data Asian Pacific TCT Perspective of LM stenting with Current registry and Randomized Clinical Data Patrick W. Serruys MD PhD Yoshinobu Onuma MD Seung-Jung Park MD, PhD 14:48-15:00, 2009 Symposium Arena, Level

More information

Update interventional Cardiology Hans Rickli St.Gallen

Update interventional Cardiology Hans Rickli St.Gallen Update interventional Cardiology 2012 Hans Rickli St.Gallen 26.11.2012 Review of Literature ESC-Highlights TCT/AHA-Highlights Update interventional cardiology 2012 Structural Heart Disease Transcatheter

More information

Summary Protocol ISRCTN / NCT REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6

Summary Protocol ISRCTN / NCT REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6 Summary Protocol REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6 Background: Epidemiology In 2002, it was estimated that approximately 900,000 individuals in the United Kingdom had a diagnosis

More information